Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KIFUderm study of Fumaderm in adolescents with moderate to severe psoriasis vulgaris
2012-000035-82Phase 3Completed
- Sponsor
- Biogen
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in plaque psoriasis comparing Fumaderm with Placebo (2 arms). Primary endpoint: PASI-75 and/or PGA 0 or 1. Started Sep 2012; status: completed.
02
Drugs
Fumaderm
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2012-000035-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000035-82.